Skip to content

Epitech Research

Active Private limited companyfounded 2023active for 3 yearsWaterleliënlaan 32, 1160 AuderghemKBO/BCE: BE 0798.532.110

Lifetime

3 annual accounts with figures on one time axis
peak of €59,658 in 2025
€59,658▲ 34.7%
peak of €42,836 in 2025
€42,836▲ 38.4%
peak of €115,399 in 2025
€115,399▲ 59.0%
€17,175▲ 75.1%
Board1 name since 2023
1 director
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Gross margin from €44,299 to €59,658Result from €30,943 to €42,836Equity from €72,563 to €115,399Debts from €9,810 to €17,175Cash from €66,465 to €94,651

Key points

from the 2025 annual accounts

Equity

€115,399 ▲ 59.0%

Epitech Research has made a profit in every financial year since 2023.

Turnover

≈ €180,000 estimated

The micro format states no turnover.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as Epitech Research has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for Epitech Research. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 10 sharesdeed of 20-02-2023
  • 90 sharesdeed of 20-02-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0798532110
Incorporation Founding capital of €2,500, 100 shares · Founded by and · appointed as director · published on 20-02-2023 · Gazette deed
First establishment Waterleliënlaan 32, Auderghem
All 9 events

Comparable companies

same main activity, similar in size and age
Company
Epitech Research Auderghem €132,574 €59,658 87.0% -
Aquature Technologies Antwerp €122,734 €43,790 52.1% 0.3
JESSAV Oosterzele €136,083 €88,416 1.9% -
Dr. Bogaerts Cardiologie Affligem €118,586 €69,422 85.6% -
DEDAL Ixelles €139,276 €73,605 70.7% -
PDVT Molenbeek-Saint-Jean €91,865 €35,353 66.0% -
Bio-Perspectives Ixelles €206,760 €104,857 81.3% -

These companies have the same main activity as Epitech Research: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €91,900 and €207,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 16-02-2023Normal situation
Activity
Research and development on biotechnologyNACE 72101and 1 other
Establishment unit
2.341.718.9661160 Auderghem, since 16-02-2023
Financial year end
31 December
Peppol
Reachable since 30-12-2025
Company details

Annual accounts 2025

€132,574▲ 60.9%
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on Epitech Research

Epitech Research files the micro format. That format states no turnover. The gross margin rose from €50,797 in 2023 to €59,658 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Epitech Research

What is the company number of Epitech Research?
The company number of Epitech Research is 0798.532.110. The VAT number is the same number with BE in front: BE 0798.532.110.
Where is Epitech Research based?
The registered office is at Waterleliënlaan 32, 1160 Auderghem.Company details
What does Epitech Research do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Epitech Research?
Epitech Research is a private limited company (BV).
When was Epitech Research founded?
Epitech Research was founded on 16-02-2023.
Is Epitech Research still active?
Yes, Epitech Research is an active enterprise in the KBO register.
What is the turnover of Epitech Research?
The turnover in financial year 2025 is about €180,000. This figure is estimated from the gross margin of €59,658 and 2,990 comparable companies of the same size. It probably lies between €120,000 and €310,000. It is a rough estimate.Financials
Is Epitech Research profitable?
In financial year 2025, Epitech Research made a profit of €42,836.
Where can I find the annual accounts of Epitech Research?
Epitech Research filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Epitech Research due?
Epitech Research must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.